Patients with dementia might be at greater risk for undertreatment of pain.

(Morrison, R. S., & Siu, A. L. (2000). A comparison of pain and its treatment in advanced dementia and cognitively intact patients with hip fracture. Journal of pain and Symptom management, 19(4), 240-248.)

           

Under treatment of pain in elderly has been examined and demonstrated. Elderly surgical patients receive less analgesic than younger patients. Patients with dementia might be at greater risk for undertreatment of pain.

Purpose of the study:

To compare analgesic prescribing in hip fracture patients with normal cognitive function to hip fracture patients with advanced dementia, and to examine the adequacy of analgesic prescribing in cognitively intact group as an approximation for those unable to report their pain.

Method:

Sample:  97 sample (38 in dementia group and 59 in cognitive intact group).  3 of 38 in dementia group had nonoperative management of their fracture.

Inclusion criteria

-  Patients aged 70 years or older admitted to the hospital with a diagnosis with hip fracture (femoral neck or intertrochanteric fracture) during Sep 1, 1996 to march 1, 1998.  -  Patients scoring 18 or greater out of 24 of the Mini-Mental State Exam were eligible for enrollment in the cognitively intact group.

-  Patients with a history of dementia and a Reisberg Global Deterioration Scale stage 6 or 7 (severe to very severe dementia) were enrolled in the dementia group.

Exclusion criteria

-  Patients who had a concomitant diagnosis of cancer, multiple internal injuries, a previous fracture in the affected hip.

-  Non English speaking.

-  Patients with delirium on admission and those with delirium as documented by the Confusion Assessment Method (CAM) on 2 consecutive days following admission.

-  Patients with mild cognitive impairment.

Setting: a New York City teaching hospital.

Tools: Confusion Assessment Method (CAM), 5-point pain rating scale (0-no pain to 4-very severe), and pain management index (PMI).

PMI is used as an indicator of the adequacy of analgesic prescribing. PMI is constructed by subtracting the patient’s self report of pain (0-no pain, 1-mild pain, 2-moderate pain, 3-severe pain) from the strongest analgesic prescribed (0-none, 1-nonopioid, 2-weak opioid, 3-strong opioid). Subjects with a PMI score less than zero have been prescribed inadequate analgesia for their level of pain.

Procedure

  Informed consent was obtained from all cognitively intact adults and from surrogate decision makers of subjects with dementia.         

  Patient interview

- cognitively intact patients daily rated the severity of their average pain on the pain rating scale over the preceding 24 hours and rated the severity of their worst episode of pain, while in bed or sitting in a chair, over the previous 24 hours. Patients also were evaluated for the presence of delirium using the CAM.  Patients who were found to be delirious were not assessed their pain on that day so as to obtain accurate recall of their pain.  Patients with dementia were also assessed for delirium using CAM and reviewing charts for health care provider notation.        

Charts were reviewed daily for information about analgesic agents; name, dose, and frequency of administration (standing or as needed). Aspirin administered as a 325 mg standing dose once per day was not considered as analgesic. Medications were classified according to WHO Analgesic Ladder as nonopioids (NSAIDs), weak opioids or strong opioids. No patient received parenteral NSAIDs in this study. Doses of all oipoids, except oxycodone, were converted into parenteral morphine sulfate equivalents using published equianalgesic dosing guideline. For oxycodone, an equianalgesic ratio of 1 mg of oxycodone to 1.5 mg of morphine sulfate (based on recent published data) was used.            

Cognitively intact subjects who reported moderate to severe pain were used to determine the PMI scores. PMI scores were calculated for subjects who could be assessed preoperatively and for the first three postop days in all subjects of this group. An average of the worst pain scores reported for each of these three days and the strongest analgesic prescribed were used to compute the PMI scores.

Results

Cognitively intact group received significant higher dose of parenteral morphine sulfate than the dementia group during preoperative period (2.6 mg in cognitive group versus 1.2 mg in dementia group), and through postoperative day 3 (4.1 mg versus 1.5 mg).

Some patients from both groups did not have a standing order (ATC) for an analgesic agent (opioids or nonopioids) for their entire hospitalization (83% in cognitive group and 76% in dementia group=not sig different between group).              

           

For pain severity in cognitively intact group, 75% (31 of 38) reported their worst pain as severe to very severe and 43% (16 of 38) reported their average level of pain as severe to very severe during pre-op period. For 3 post-op days, 81% (46 of 57) reported at least one episode of severe pain and 42% reported their average level of pain to be severe to very severe.      

PMI scores- 37 of 38 patients, who pain scores are available for pre-op period, experienced at least one episode of moderate to severe pain, and 22 of these 37 patients (59%) had a PMI score of less than 0. For post-op period, 52 of 58 patients (90%) had a mean worst pain score that was moderate to very severe, and 26 of these 52 patients had a PMI score of less than 0. 

Summary         

  Pain was substantially untreated or undertreated in geriatric hip fracture patients especially in patients with dementia.

 

RETURN TO PREVIOUS PAGE